Laboratory Medicine ›› 2021, Vol. 36 ›› Issue (3): 245-249.DOI: 10.3969/j.issn.1673-8640.2021.03.003
Previous Articles Next Articles
Received:2020-10-12
Online:2021-03-30
Published:2021-03-30
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2021.03.003
| [1] | MILLER W G, SCHIMMEL H, REJ R, et al. IFCC working group recommendations for assessing commutability part 1:general experimental design[J]. Clin Chem, 2018,64(3):447-454. |
| [2] | Clinical and Laboratory Standards Institute. Characterization and qualification of commutable reference materials for laboratory medicine;approved guideline[S]. EP30-A,CLSI, 2010. |
| [3] | Clinical and Laboratory Standards Institute. Evaluation of commutability of processed samples;approved guideline—third edition[S]. EPl4-A3,CLSI, 2014. |
| [4] |
NILSSON G, BUDD J R, GREENBERG N, et al. IFCC working group recommendations for assessing commutability part 2:using the difference in bias between a reference material and clinical samples[J]. Clin Chem, 2018,64(3):455-464.
DOI URL PMID |
| [5] |
BUDD J R, WOYKAMP C, REJ R, et al. IFCC working group recommendations for assessing commutability part 3:vsing the calibration effectiveness of a reference material[J]. Clin Chem, 2018,64(3):465-474.
DOI URL PMID |
| [6] |
FASCE C F Jr, REJ R, COPELAND W H, et al. A discussion of enzyme reference materials:applications and specifications[J]. Clin Chem, 1973,19(1):5-9.
URL PMID |
| [7] | 陈文祥, 申子瑜, 郭健, 等. 临床检验量值溯源中的重要术语与概念及有关问题[J]. 中华检验医学杂志, 2005,28(2):142-146. |
| [8] | 胡丽涛, 王薇, 王治国. 回归和多元分析在参考物质互换性研究中的应用[J]. 中国卫生统计, 2012,29(3):462-464. |
| [9] |
BRAGA F, PANTEGHINI M. Commutability of reference and control materials:an essential factor for assuring the quality of measurements in laboratory medicine.[J]. Clin Chem Lab Med, 2019,57(7):967-973.
DOI URL PMID |
| [10] | National Committee for Clinical Laboratory Standard. Preparation and validation of commutable frozen human serum pools as secondary reference materials for cholesterol measurement procedures;approved guideline[S]. C37-A,NCCLS, 1999. |
| [11] | 杨宗兵, 王军, 孙京昇, 等. 载脂蛋白AⅠ国家标准物质的互换性评价[J]. 临床检验杂志, 2015,33(12):934-935. |
| [12] | SANDBERG S, FRASER C G, HORVATH A R, et al. Defining analytical performance specifications:consensus statement from the 1st strategic conference of the european federation of clinical chemistry and laboratory medicine[J]. Clin Chem Lab Med, 2015,53(6):833-835. |
| [13] | 陈宝荣, 邵燕, 刘春龙, 等. 不同评价方法对标准物质互换性评价结果的影响[J]. 临床检验杂志, 2016,34(11):808-812. |
| [14] |
DELATOUR V, LIU Q, VESPER H W, et al. Commutability assessment of external quality assessment materials with the difference in bias approach:are acceptance criteria based on medical requirements too strict?[J]. Clin Chem, 2016,62(12):1670-1671.
URL PMID |
| [15] |
CAROBENE A. Reliability of biological variation data availablein an online database:need for improvement[J]. Clin Chem Lab Med, 2015,53(6):871-877.
DOI URL PMID |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | ZHOU Ying, REN Yihui, LI Guangming. Serum miR-148a expression in children with autoimmune hepatitis and its correlation with inflammatory factors [J]. Laboratory Medicine, 2023, 38(12): 1130-1134. |
| [5] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [6] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [7] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [9] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [10] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [11] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [12] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [13] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
